Tirzepatide is a synthetic peptide analogue studied in dual GIP and GLP-1 receptor pathway research. Scientific literature discusses it in relation to incretin signalling, metabolic models, glucose-regulation pathways, and body-weight research endpoints.
This product is supplied strictly for lawful research, laboratory, analytical, educational, or R&D purposes where permitted by applicable law. It is not intended for human or animal use.




